SEC 13F Intelligence

Camber Capital Management LP / APLSUSD

Camber Capital Management LP’s Apellis Pharmaceuticals Inc Position

Does Camber Capital Management LP own Apellis Pharmaceuticals Inc (APLSUSD)? Yes850.0K shares worth $15M (+1.38% of its 13F portfolio) as of Q2 2025.

Position Value
$15M
Q2 2025
Shares
850.0K
% of Portfolio
+1.38%
Quarters Held
1
currently held

Position History APLSUSD

Reported value by quarter
Q2 ’25: $15MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025850.0K$15M+1.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Camber Capital Management LP’s full portfolio or all institutional holders of APLSUSD.